STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMSStandard Exclusive License Agreement • August 28th, 2020 • Alzamend Neuro, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 28th, 2020 Company IndustryThis Agreement is made effective nunc pro tunc November 1, 2019, (the “Effective Date”) by and between the University of South Florida Research Foundation, Inc. (hereinafter called “ Licensor”), a nonstock, nonprofit Florida corporation, under Chapter 617 Florida Statutes, and a direct support organization of the University of South Florida (“University”) pursuant to section 1004.28 Florida Statutes and Alzamend Neuro Inc. (hereinafter called “Licensee”), a small corporation organized and existing under the laws of Delaware;
STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMSStandard Exclusive License Agreement • August 28th, 2020 • Alzamend Neuro, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 28th, 2020 Company IndustryThis Agreement is made effective nunc pro tunc November 1, 2019, (the “Effective Date”) by and between the University of South Florida Research Foundation, Inc. (hereinafter called “ Licensor”), a nonstock, nonprofit Florida corporation, under Chapter 617 Florida Statutes, and a direct support organization of the University of South Florida (“University”) pursuant to section 1004.28 Florida Statutes and Alzamend Neuro Inc. (hereinafter called “Licensee”), a small corporation organized and existing under the laws of Delaware;
STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMS Agreement # Number LIC18056.Standard Exclusive License Agreement • May 14th, 2020 • Gratitude Health, Inc. • Beverages
Contract Type FiledMay 14th, 2020 Company IndustryThis Agreement is made effective January 8, 2018, (the “Effective Date”) by and between the University of South Florida Research Foundation, Inc. (hereinafter called “Licensor”), a nonstock, nonprofit Florida corporation, under Chapter 617 Florida Statutes, and a direct support organization of the University of South Florida (“University”) pursuant to section 1004.28 Florida Statutes and Gratitude Health, Inc. (hereinafter called “Licensee”), a small entity corporation organized and existing under the laws of Florida;
STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMSStandard Exclusive License Agreement • September 29th, 2016 • Alzamend Neuro, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 29th, 2016 Company IndustryThis Agreement is made effective May 1, 2016, (the “Effective Date”) by and between the University of South Florida Research Foundation, Inc. (hereinafter called “ Licensor”), a nonstock, nonprofit Florida corporation, under Chapter 617 Florida Statutes, and a direct support organization of the University of South Florida (“University”) pursuant to section 1004.28 Florida Statutes and Alzamend Neuro Inc. (hereinafter called “Licensee”), a small corporation organized and existing under the laws of Delaware;